Clover Health Investments, Corp.
NASDAQ:CLOV
3.46 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 1,371.131 | 1,260.543 | 1,096.552 | 1,471.996 | 672.888 | 462.266 | 281.022 |
| Kosten van de omzet
| 1,006.327 | 1,004.59 | 993.073 | 1,551.178 | 590.082 | 449.701 | 0 |
| Brutowinst
| 364.804 | 255.953 | 103.479 | -79.182 | 82.806 | 12.565 | 281.022 |
| Brutowinstmarge
| 0.266 | 0.203 | 0.094 | -0.054 | 0.123 | 0.027 | 1 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 408.934 | 440.246 | 482.403 | 445.745 | 192.086 | 187.327 | 103.04 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 84.242 |
| Verkoop-, algemene en administratieve kosten
| 408.934 | 440.246 | 482.403 | 445.745 | 192.086 | 187.327 | 187.282 |
| Overige kosten
| 1.619 | 21.036 | -92.26 | 112.065 | -16.573 | 8.437 | 0 |
| Bedrijfskosten
| 410.553 | 461.282 | 390.143 | 557.81 | 175.513 | 195.764 | 475.996 |
| Bedrijfsresultaat
| -45.749 | -205.329 | -286.664 | -636.992 | -92.707 | -183.199 | -185.797 |
| Bedrijfsresultaat ratio
| -0.033 | -0.103 | -0.107 | -0.433 | -0.138 | -0.396 | -0.661 |
| Totaal overige inkomsten en kosten netto
| -0.517 | -4.819 | 32.08 | 49.236 | -43.685 | -180.538 | -16.131 |
| Inkomen voor belasting
| -46.266 | -210.148 | -254.584 | -587.756 | -136.392 | -363.737 | -201.928 |
| Inkomen voor belasting ratio
| -0.031 | -0.105 | -0.097 | -0.399 | -0.136 | -0.787 | -0.719 |
| Belastingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | -16.131 |
| Nettowinst
| -43.009 | -213.361 | -339.567 | -587.756 | -136.392 | -363.737 | -201.928 |
| Nettowinstmarge
| -0.031 | -0.105 | -0.088 | -0.411 | -0.221 | -0.871 | -0.719 |
| WPA (Winst Per Aandeel)
| -0.08 | -0.45 | -0.71 | -1.25 | -0.23 | -0.9 | -4.81 |
| Verwaterde WPA
| -0.08 | -0.45 | -0.71 | -1.25 | -0.23 | -0.9 | -4.81 |
| EBITDA
| -44.935 | -207.632 | -252.034 | -569.6 | -78.729 | -324.118 | -16.131 |
| EBITDA ratio
| -0.033 | -0.104 | -0.106 | -0.432 | -0.137 | -0.395 | -0.057 |